Press release
From a Parkinson's Diagnosis That Stole Her Speech, a Poet Finds Her Voice
From Parkinson's to a Poet: Laughter and Tears Poetry Collection by Melody EddinsMARIETTA, GA - When a Parkinson's diagnosis threatened to silence Melody Eddins, she found her voice in verse. Her book, From Parkinson's to a Poet: Laughter and Tears Poetry Collection [https://www.amazon.com/Parkinsons-poet-Melody-Eddins/dp/1480839035/], transforms a life-altering diagnosis of Parkinson's disease into a stirring testament of resilience, faith, and humor.
The collection offers an intimate portrait of a woman diagnosed with Parkinson's disease in 2011. After retiring in 2014, Eddins turned to writing as therapy. What began as an effort to ease the hesitations and stumbles in her speech grew into a body of poetry that speaks to anyone who has faced life's obstacles.
The poems move between laughter and tears. Some capture raw moments of struggle, while others find humor in the absurdities of a body that no longer always follows instructions. Throughout, Eddins introduces the characters who shaped her journey: steadfast family, moments of divine grace, and the small mercies that arrive when needed most.
"As I walk this journey, I may stumble and fall. I may even freeze at times or have no expression at all. I continue to shake, rattle, and roll, but there will always be peace way down in my soul."
These opening lines set the tone for a collection that offers no pretense, only an unvarnished and hopeful portrait of a life lived with purpose.
From Parkinson's to a Poet: Laughter and Tears Poetry Collection is available on Amazon [https://www.amazon.com/Parkinsons-poet-Melody-Eddins/dp/1480839035/].
About the Author
Melody Eddins was diagnosed with Parkinson's disease in 2011 and retired in 2014. Writing became her therapy and, unexpectedly, her creative voice. She writes about faith, family, and the moments that define a life. She resides in Jefferson, South Carolina.
About Author's Tranquility Press
Author's Tranquility Press is a full-service publishing and media platform dedicated to amplifying voices that inspire, heal, and connect. With a focus on meaningful storytelling, the press works alongside authors to bring their work to readers with care, professionalism, and a deep respect for the written word.
Media Contact
Company Name: Author's Tranquility Press
Contact Person: Louela Sanders - Marketing Fulfillment Associate
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=from-a-parkinsons-diagnosis-that-stole-her-speech-a-poet-finds-her-voice]
Phone: (866) 411-8655
Address:531 Roselane Street NW Suite 400-175
City: Marietta
State: Georgia, 30060
Country: United States
Website: http://www.authorstranquilitypress.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release From a Parkinson's Diagnosis That Stole Her Speech, a Poet Finds Her Voice here
News-ID: 4442603 • Views: …
More Releases from ABNewswire
MakeForms and Keragon Come together to Automate Healthcare Workflows
Healthcare organizations can now connect MakeForms' HIPAA-compliant forms directly into Keragon's automation platform - with scheduling and e-signature support on the way.
Delaware, USA - March 26, 2026 - MakeForms, the privacy-first online form builder [https://makeforms.io/] built for healthcare organizations, hospitals, and NGOs, today announced a native integration with Keragon, the leading HIPAA-compliant healthcare automation platform. Healthcare teams can now connect MakeForms directly into Keragon's no-code workflow engine - moving patient…
New Zealand Motorhome Buyers Shift Focus Towards Ownership Support as Travel Hab …
Auckland, New Zealand - 26 March, 2026 - Motorhome purchasing behaviour across New Zealand is undergoing a noticeable shift, with buyers increasingly prioritising ownership support, servicing confidence, and long-term guidance over traditional considerations such as vehicle specifications alone.
Industry participants say the change reflects broader lifestyle trends influencing how households approach travel, recreation, and discretionary spending. As domestic tourism continues to play an important role in travel planning, many New Zealanders…
Edimakor Unveils AI Video Enhancer: Transforming Ordinary Footage into Cinematic …
NEW YORK, N.Y. - March 26, 2026 - Every creator faces the same problem at some point - footage that doesn't look good enough. Low resolution, blurry details, unwanted noise, or shaky camera movement can ruin an otherwise great video.
Now, there's a simple solution... HitPaw Edimakor introduces its AI Video Enhancer [https://edimakor.hitpaw.com/features/video-enhancer.html] - a powerful tool designed to turn ordinary clips into clear, professional-quality visuals. With advanced AI technology -…
Belitsoft Reviews: How DevOps Survives in the Era of AI-Generated Code
Using AI to make developers faster does not make much sense if your delivery pipeline is slow. Best practices in 2026 are to upgrade your CI/CD infrastructure with AI automation (AIOps, agentic workflows, AI agents as pipeline operators), selective testing (running only relevant tests based on code changes), and parallel processing. However, according to Belitsoft [https://belitsoft.com/], this requires advanced DevOps engineering skills.
AI coding assistants and generative AI tools significantly boost…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
